Alexander Mayweg - Profile and Investment Details

Investor Profile

Alexander Mayweg is a Venture Capital, Private Equity Firm based in Switzerland with a diverse investment portfolio that includes companies such as Black Diamond Therapeutics, Granite Bio, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics, Aprea, CODA Biotherapeutics, Therachon, Inception IBD, Monteris Medical, Zyga Technology, Inari Medical, Century Therapeutics, Ceterix Orthopaedics, Audentes Therapeutics, Gotham Therapeutics, GenSight BiologicsMatterhorn Biosciences, Ventus Therapeutics, Benvenue Medical, Pandion Therapeutics, T-knife, Vividion Therapeutics, NeuWave Medical, PIQUR Therapeutics, Tarveda Therapeutics, VectivBio, Akero Therapeutics, Crinetics Pharmaceuticals, Graphite Bio, Jecure Therapeutics, RayzeBio, BlueRock Therapeutics, Sebacia, Repare Therapeutics, Enterprise Therapeutics, Kinestral Technologies, Serac Therapeutics, Intuity Medical, Metavention, Tempest Therapeutics, Bright Peak Therapeutics, Veran Medical Technologies, Respicardia, Nouscom, Red Ridge Bio, Nuvaira, Quentis Therapeutics, Passage Bio, Turnstone Biologics, Oyster Point Pharmaceuticals, Chinook Therapeutics, Monte Rosa Therapeutics, Pipeline Therapeutics, Twelve, Venatorx Pharmaceuticals, SixPeaks Bio, Gritstone Oncology, Jnana, Ebb Therapeutics, Lava Therapeutics, ROX Medical, Revelio Therapeutics, AcuFocus, Anokion, Ivantis, Laguna Pharmaceuticals, . Over time, Alexander Mayweg has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alexander Mayweg is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Genetics, Wellness, Women Founded, Life Science, Biotechnology, Medical Devices, Genomics, Health Diagnostics, Digital Health, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Alexander Mayweg, as their portfolio suggests a familiarity and interest in this area.

Understanding Alexander Mayweg’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.